Security key
293602405
Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (ENSC)
CUSIP: 293602405
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 20,964
- Total 13F value
- $101,378
- Share change
- +20,964
- SEC-reported price per share
- $4.84
- Number of holders
- 7
- Value change
- +$101,378
- Number of buys
- 7
- Shares outstanding
- 19,603,857
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
7
Top holders
7
ENSC full security history
Ownership snapshot
Full 13F holder table
Ensysce Biosciences, Inc. SEC filings
Ensysce Biosciences, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ENSC - Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
A. Lorne Weil
Disclosed value leader
A. Lorne Weil
Comparable rows
0/15
Latest evidence
02 Mar 2023
3/4/5
13F
Highest disclosed value: $1,868,005
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
A. Lorne Weil has the largest disclosed position value at $1.87M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens A. Lorne Weil's linked filing trail.
Disclosed position value
Top 5
A. Lorne Weil
$1.87M
Daniel B. Silvers
$1.75M
William H. Chang
$1.27M
Bob G. Gower
$597K
Lynn Kirkpatrick
$186.5K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| A. Lorne Weil |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$1,868,005
1,868,005 shares
|
— | 30 Jun 2021 |
| Daniel B. Silvers |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$1,754,497
1,754,497 shares
|
— | 30 Jun 2021 |
| William H. Chang |
3/4/5
Director, 10%+ Owner
|
—
mixed-class rows
|
$1,267,451
2,630,640 shares
mixed-class rows
|
— | 23 Jun 2022 |
| Bob G. Gower |
3/4/5
Director
|
—
class O/S missing
|
$597,036
1,222,682 shares
|
— | 02 Mar 2023 |
| Lynn Kirkpatrick |
3/4/5
Chief Executive Officer, Director
|
—
mixed-class rows
|
$186,458
2,898,790 shares
mixed-class rows
|
— | 25 May 2022 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
class O/S missing
|
$31,708
42,277 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
20,964
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q1 2023 Across Filers
Q1 2023 holders
7
Q1 2023 holders
7
Holder diff
0
| Investor | Q1 2023 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q1 2023 value | Value change | Value Chg % |
|---|